Ph
1Radi
INTRTumordetectiorthotovariantutility MATEDetermisotherphytateBiodisSpraguperformElucidEvaluaRAW2were wInoculpenicilinoculadiametMRI: Germams, wicalculaadmini= 30×3RESUDetermsaturatdata suBiodisbiodisth in th(PB) smacropElucidcontrasspecifiEvaluashowni.e., 16Detecthypo-iand preDoxorhas higwere fuDISCPhytatechemicphysiotherefodirect dand tumREFE[1] SteHill RHarisinACKNThis w
hytate-Comp
iology, Seoul Nat
RODUCTION r-associated macropion of tumors with opic murine model t by combining the of this novel antitumERIALS AND Mmination of the Thrmal titration microce solution. To minimstribution of ICPCue–Dawley (SD) ratmed to confirm the dation of ICPC Uptation of ICPC as
264.7 macrophages washed with PBS, anlation of B16F1 Mellin-streptomycin. Bated 8-week-old C5ter. MRI scans wereMRI studies were
any). For the estimatith a step size of 1.0ated using Matlab istration of ICPC (n30 mm2; matrix sizeULTS mination of the Thtion in accordance wupport the use of ICstribution of ICPCtribution and retentie liver and at 8 h in
staining (data not sphages, in particula
dation of ICPC Upst, residential peritoic. These data strongation of ICPC as a in Fig. 2d. The ICP
6-fold higher than thtion of Metastatic ntense LN metastasedominantly engulf
rubicin-ICPC Comgh affinity for doxofurther confirmed byCUSSION
e has long been usecal nature of phytate
ological conditions [ore distinct from thadetection of tumor mmor-specific drug dRENCES
eidl C, NEJM 362, 8P, Science 224, 998nghani MG, NEJM
NOWLEDGEMENwork was supported
plex as a Nove
tional University
phages (TAMs) accuhigh specificity. Heof metastatic melan ICPC with an antimor MR agent that
METHODS hermodynamics of calorimeter (Microcmize the ability of F
C and Identificationts. The biodistributiidentity of the cellstake by Macrophaan Effective Macwere cultured in 10nd ICPC-labeled ceelanoma Mice: B1
B16F1 cells were tr57BL/6 male mice e then performed for
performed on a 9.tion of relaxation ra0 ms. Other imagin(MathWorks Inc.,
n=9). A GE and a spe = 384×384; 15 slic
hermodynamics ofwith a two-site set mPC as an injectable
C and Identificatiion time in C57BL/
n the spleen. Other thown). These resu
ar hepatic Kupffer ceptake by Macrophaoneal macrophages gly suggest that ICPan Effective MacrPC alone had an esthat of ICPC alone (FLymph Nodes in Bsis is clearly detectfed by F4/80+ macro
mplex (Dox@ICPCorubicin (22.7 nM).y PB staining.
ed for the detection e is ideally suited fo[3]. Activated macroat of iron-oxide nanmetastases. Our pre
delivery simultaneou
875 (2010). [2] Dald8 (1984). [6] Sewa348, 2491 (2003). TS by Korean Ministry
el MRI Agent
Hospital, Seoul,
umulate in various ere, we developed anoma. Beyond the icancer drug. Usingachieves both TAM
Fe3+ Binding to Phcal, USA) [3]. Base
Fe3+-phytate to chelan of the Cells that ion and retention tims that absorbed ICPCages: we used thioglcrophage-specific M0-cm2 plates at a deells were prepared in6F1 melanoma cellansfected with an Fwith 4×105 B16F1 r metastatic lymph n.4 T MR scanner wate (R2*) and relaxig parameters were:USA). For in vivo
pin echo sequence (ces (0.5 mm); NEX
f ICPC: Fig. 1a illumodel, in which Fe3
MRI contrast agenton of the ICPC-A/6 mice are shown itissues, including thlts support the appells (Fig. 1e) and sinages: LPS-stimulatdid not ingest ICPC
PC is selectively engrophage-specific Mtimated r2
* of 82.9 ±Fig. 2e). B16F1-GFP Melaned. These findings ophages within tumo): Fig.3c illustrates In Fig. 3d, fluores
of sentinel LNs in or simultaneously bophages are then ab
noparticles, which caeliminary data also susly.
drup-Link HE, Clinatkar AB, Nucl Med
y of Educational Sci
t for Tumor A
Hyeonjin Seoul, Korea, Rep
cancers and promoan iron-calcium-phycapability of curren
g a Doxorubicin-ICPM-specific MR imag
hytate and Prepared on our ITC resultate Ca2+ from the blAbsorbed ICPC: me of ICPC were eC. lycollate-elicited peMRI Probe: ICPCensity of 2 × 106 cen PCR tubes. s were cultured in DFG12 lentiviral vector B16F1-GFP menode (LN) imagingwith a transmit-onlyivity (r2*) of ICPC TR = 8000 ms; flip
o LN imaging in aSE) were used (resp= 8).
ustrates the thermod3+ ions bind one set t, due to its stability
Absorbing Cells :n Figs. 1c and 1d, r
he brain, heart, lung,plication of ICPC anusoidal lining cellsed TEPM more effC. As an additional gulfed by activated
MRI Probe: Fig. 2c± 3.1 mM-1s-1. Incub
noma Mice In Vivowere confirmed byor regions, as the an the thermodynami
scence analysis clea
cancer patients in thinding Fe3+ and Ca2
ble to engulf these inan also localize to hstrongly support tha
Cancer Res, 17, 56d (Stuttg) 14, 46 (1
ience and Technolo
Associated MDelivery
Kim1, and Byungepublic of, 2Lee G
Republic of
ote tumor angiogenytate complex (ICPnt TAM imaging mPC complex (Dox@
ging and tumor-spec
ration of ICPC: wets, a 10 mM solutiolood, equimolar conThe clearance of IC
examined in C57BL
eritoneal macrophagC alone and ICPC-lells mL-1 in a mediu
DMEM complete mtor that expressed g
elanoma cells per mg. Regional LNs (lefy volume coil for in vitro, a gradient p angle (FA) = 90º;animals, we perforpiratory-gated and f
dynamics of ICPCt of binding sites wiy under physiologic
The clearance of respectively. ICPC c, kidney, lymph nodas an MRI agent fos of the spleen (Fig.ficiently engulfed ICl control, B16F1 memacrophages.
c shows the MR imbation of macrophag
o: Fig. 3a shows thy GFP fluorescence ntibody staining comics of Dox@ICPC oarly demonstrated th
the form of techneti2+ ions and even an nsoluble ICPC partihealthy LNs [9]. In sat the novel antitum
695 (2011). [3] Kim1975). [7] Ege GN,
ogy (2010-0024500,
Macrophage (T
g-Chul Oh2 Gil Ya Cancer and
nesis and progressioPC) as an MRI agenmethods, which is lim@ICPC), we also pcific drug delivery si
e performed isothermon of Fe3+-phytate wncentrations of Ca2+
CPC from blood waL/6 mice. Immunohi
ges (TEPM) from wlabeled RAW264.7 um (ICPC concentr
medium (Sigma-Aldrgreen fluorescence p
mouse via the left frft axillary and brachexcitation and a phecho sequence (GE; FOV = 60×60 mmrmed MRI scans bfat-suppressed; TR/
obtained by ITC anith high affinity (4.6al conditions [3]. ICPC from blood
clearance from the bde, and thymus, shoor use in vivo. The. 1f) [6]. CPC in a dose-depeelanoma cells did n
mages used for the eges with various con
he pre- and post-coand PB staining (F
mpletely overlappedobtained by ITC anhat Dox@ICPC wa
ium-phytate (Tc-phyanticancer drug suc
icles [8]. The abilitysummary, we have
mor MR agent, Dox@
m OH, Biochemistry, J Nucl Med 19, 1
, 2011-0002622).
TAM)-specifi
d Diabetes Institu
on [1], and thus mint that specifically tmited to visualizatiresent our preliminimultaneously.
mal titration calorimwas prepared by mix
ions were added to as investigated afteristochemical (IHC)
wild-type mice, whicmacrophages were
ations ranging 0 - 0
rich, USA) with 10%protein (GFP) underont footpad [5]. Thhial) and non-regionhased array 4-chann) was used with 8 d
m2; matrix size = 25efore and 4, 8, 16TE = 335/6.7 ms fo
nalyses. Titration of62 μM) and bind an
after i.v. injectionblood was rapid. Mwed very low level IHC results clearl
endent manner, as cot take up ICPC (F
estimation of R2* oncentrations of ICP
ntrast MR images oFig. 3b). IHC analysd the PB staining (Fnalysis. Titration of as selectively targete
ytate), an establishech as doxorubicin, sy of ICPC to target adeveloped a tumor-@ICPC, may potent
y 49, 10216 (2010). 1362 (1978). [8] Gu
fic Image Con
ute, Gachon Univ
ight be ideal imagintargets TAMs, and ion of TAMs [2], wnary results that stro
metry (ITC) experimxing equimolar conco the Fe3+-phytate sor i.v. injection of th) staining using an a
ch represent inflamme imaged for relax0.3 mM). After incu
% heat-inactivated Fer the control of thehe tumor was allownal LNs were harvesnnel surface coil fordifferent echo times 56×256; 1 slice (0.56, and 24 h after ior GE and 4000/58 m
f Fe3+ into phytate nother set with low
n (10 μmol⋅kg-1) inMaximal ICPC uptak
ls of ICPC uptake, aly showed that ICP
compared to unstimFig. 2b), confirming
of ICPC in vitro. TPC resulted in an r2
*
of the B16F1-GFP sis demonstrated th
Fig. 3b). f doxorubicin into pted in tumor regions
ed radiopharmaceutsubsequently forminactivated macropha-specific MRI agenttially achieve both
[4] Kuziel WA,2. Pudewicz PW, J Ce
ntrast and Dr
versity, Incheon, K
ng targets for non-ivalidated its efficac
we also developed aongly support the p
ments using a Microcentrations of Fe3+ iolution (pH = 6.0).e agent (10 μmol⋅kantibody against F4
mation-activated celxation rate (R2*) mubation for 12 h, th
FBS (Gibco, USA) e ubiquitin C promowed to grow to ~ 1.sted from the mice.r signal reception ((TEs) ranging 3.14 mm); NEX = 4. R2ntravenous (10 μmms for SE), FA = 90
exhibited Fe3+ bindaffinity (31.25 μM)
nto SD rats as welke in the mice occuras verified by PrussPC was engulfed b
mulated TEPM (Figg that ICPC is macro
The resulting R2* mof 1056.1 ± 105.9 m
melanoma mice whhat ICPC was prefer
hytate showed that s of metastatic LNs
ical agent for PET ng insoluble particleages within tumor ret for use in the accurTAM-specific MR i
PNAS 94, 12053 (19ll Biol 87, 427 (19
rug
Korea,
invasive cy in an an ICPC potential
ocal 200 ions and
g-1) into 4/80 was
lls [4]. mapping. he plates
and 1% oter. We 0 cm in
(Bruker, 4 - 10.14 2* were
mol⋅kg-1) 0º; FOV
ding site ). These
ll as its rred at 4 ian blue y tissue
. 2a). In ophage-
maps are mM-1s-1,
here the rentially
phytate s, which
[7]. The es under egions is rate and imaging
997). [5] 980). [9]
1637Proc. Intl. Soc. Mag. Reson. Med. 20 (2012)